다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
BioMed research international, v.2014, 2014년, pp.785479 -
Marvibaigi, Mohsen (IJN-UTM Cardiovascular Engineering Center, Faculty of Biosciences and Medical Engineering, Universiti Teknologi Malaysia, 81310 Skudai, Johor, Malaysia) , Supriyanto, Eko (IJN-UTM Cardiovascular Engineering Center, Faculty of Biosciences and Medical Engineering, Universiti Teknologi Malaysia, 81310 Skudai, Johor, Malaysia) , Amini, Neda (IJN-UTM Cardiovascular Engineering Center, Faculty of Biosciences and Medical Engineering, Universiti Teknologi Malaysia, 81310 Skudai, Johor, Malaysia) , Abdul Majid, Fadzilah Adibah (Bioprocess Engineering Department, Faculty of Chemical Engineering, Universiti Teknologi Malaysia, 81310 Skudai, Johor, Malaysia) , Jaganathan, Saravana Kumar (IJN-UTM Cardiovascular Engineering Center, Faculty of Biosciences and Medical Engineering, Universiti Teknologi Malaysia, 81310 Skudai, Johor, Malaysia)
AI-Helper
Breast cancer is among the most frequent types of cancer in women worldwide. Current conventional treatment options are accompanied by side effects. Mistletoe is amongst the important herbal medicines traditionally used as complementary remedies. An increasing number of studies have reported antican...
1 Ferlay J Soerjomataram I Ervik M Cancer incidence and mortality worldwide: IARC cancer base GLOBOCAN 2012 2013 1 11
2 American Cancer Society Global Cancer Facts & Figures 2011 2nd edition Atlanta, Ga, USA American Cancer Society
3 Jemal A Bray F Ferlay J Global cancer statistics CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216
4 SEER stat fa ct sheets: breast cancer 2011, http://seer.cancer.gov/statfacts/html/breast.html
5 Prosnitz J Iglehart RR Winer E Breast cancer Clinical Oncology: A Multidisciplinary Approach for Physicians and Students 2001 New York, NY, USA Saunders 267 299
6 US Preventive Services Task Force Screening for breast cancer 2009, http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm
7 Canadian Task Force on Preventive Health Care Screening for breast cancer 2011, http://www.canadiantaskforce.ca/guidelines/2011-breast-cancer/
8 Sjöval K Strömbeck G Löfgren A Bendahl PO Gunnars B Adjuvant radiotherapy of women with breast cancer—information, support and side-effects European Journal of Oncology Nursing 2010 14 2 147 153 19896896
9 Connor C Attai D Adjuvant endocrine therapy for the surgeon: options, side effects, and their management Annals of Surgical Oncology 2013 20 10 3188 3193 2-s2.0-84882298617 23975307
10 Gianni L Cole BF Panzini I Anemia during adjuvant non-taxane chemotherapy for early breast cancer: incidence and risk factors from two trials of the International Breast Cancer Study Group Supportive Care in Cancer 2008 16 1 67 74 2-s2.0-36949006925 17629752
11 Kado K Forsyth A Patel PR Schwartz JA Dietary supplements and natural products in breast cancer trials Frontiers in Bioscience: Elite 2012 4 1 546 567 2-s2.0-84860128688
12 Mansky PJ Wallerstedt DB Complementary medicine in palliative care and cancer symptom management Cancer Journal 2006 12 5 425 431 2-s2.0-33749822696
13 Beuth J Evidence-based complementary medicine in breast cancer therapy Breast Care 2009 4 1 8 12 2-s2.0-62849108023 20877679
14 Beuth J Moss R Complementary Oncology: Adjunctive Methods in the Treatment of Cancer 2005 New York, NY, USA Thieme
15 Gerber B Scholz C Reimer T Briese V Janni W Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review Breast Cancer Research and Treatment 2006 95 3 199 209 2-s2.0-33645214868 16254687
16 Navo MA Phan J Vaughan C An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies Journal of Clinical Oncology 2004 22 4 671 677 2-s2.0-1442356712 14966090
17 Cui Y Shu X Gao Y Use of complementary and alternative medicine by Chinese women with breast cancer Breast Cancer Research and Treatment 2004 85 3 263 270 2-s2.0-3042532630 15111765
18 Büssing A Biological and pharmacological properties of Viscum album L Mistletoe. The Genus Viscum 2000 Amsterdam, The Netherlands Harwood Academic Publishers 123 182
19 Hutt N Kopferschmitt-Kubler MC Cabalion J Purohit A Alt M Pauli G Anaphylactic reactions after therapeutic injection of mistletoe ( Viscum album L.) Allergologia et Immunopathologia 2001 29 5 201 203 2-s2.0-0035189991 11720654
20 Steiner R Vortrag vom 2.4 1920; Geisteswissenschaft und Medizin GA 312 1961 312 Dornach, Switzerland Verlag der Rudolf Steiner-NachlaBverwaltung 242 262
21 Grieve M A Modern Herbal 1994 London, UK Penguin Books
22 Becker H Botany of European mistletoe (Viscum album L.) Oncology 1986 43 1 2 7 2-s2.0-0023005828 3808574
23 Klett CY Anderer FA Activation of natural killer cell cytotoxicity of human blood monocytes by a low molecular weight component from viscum album extract Arzneimittelforschung 1989 39 12 1580 1585 2-s2.0-0024347390 2624609
24 Mueller EA Anderer FA A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon γ inducer Cancer Immunology Immunotherapy 1990 32 4 221 227 2-s2.0-0025642937 2124513
25 Orhan DD Küpeli E Yesilada E Ergun F Anti-inflammatory and antinociceptive activity of flavonoids isolated from Viscum album ssp. album Zeitschrift fur Naturforschung C 2006 61 1-2 26 30 2-s2.0-33645089417
26 Winkler K Leneweit G Schubert R Characterization of membrane vesicles in plant extracts Colloids and Surfaces B: Biointerfaces 2005 45 2 57 65 2-s2.0-24644502131 16125916
27 Jäger S Winkler K Pfüller U Scheffler A Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L. Planta Medica 2007 73 2 157 162 2-s2.0-34250302748 17415876
28 Kienle G Kiene H Die Mistel in der Onkologie: Fakten und Konzeptionelle Grundlagen 2003 New York, NY, USA Schattauer
29 Büssing A Mistletoe. The Genus Viscum 2000 Amsterdam, The Netherlands Hardwood Academic Publishers
30 Zee-Cheng RK Anticancer research on Loranthaceae plants Drugs of the Future 1997 22 5 519 530 2-s2.0-0030812528
31 Bar-Sela G White-Berry mistletoe (Viscum album L.) as complementary treatment in cancer: does it help? European Journal of Integrative Medicine 2011 3 2 e55 e62 2-s2.0-79961017270
32 Bussinga A Suzartb K Bergmannc J Pfiillefl U Schietzek M Schweizerb K Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins Cancer Letters 1996 99 59 72 8564930
33 Hajto T Hostanska K Fischer J Saller R Immunomodulatory effects of Viscum album agglutinin-I on natural immunity Anti-Cancer Drugs 1997 8 1 S43 S46 2-s2.0-0030921399 9179367
34 Pryme IF Bardocz S Pusztai A Ewen SWB Suppression of growth of tumour cell lines in vitro and tumours in vivo by mistletoe lectins Histology and Histopathology 2006 21 3 285 299 2-s2.0-29844438773 16372250
35 Voelter W Wacker R Stoeva S Tsitsilonis R Betzel C Mistletoe lectins, structure and function Frontiers in Natural Product Chemistry 2005 1 1 149 162
36 Endo Y Tsurugi K Franz H The site of action of the A-chain of mistletoe lectin I on eukaryotic ribosomes The RNA N-glycosidase activity of the protein FEBS Letters 1988 231 2 378 380 2-s2.0-0024296613 3360143
37 Bantel H Engels IH Voelter W Schulze-Osthoff K Wesselborg S Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis Cancer Research 1999 59 9 2083 2090 2-s2.0-0033135490 10232592
38 Hajto T Hostanska K Weber K Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo Natural Immunity 1998 16 1 34 46 2-s2.0-0031794944 9789123
39 Lee C Kim J Kim H Park S Lee S Immunomodulating effects of Korean mistletoe lectin in vitro and in vivo International Immunopharmacology 2009 9 13-14 1555 1561 2-s2.0-70350564317 19788934
40 Beuth J Stoffel B Ko HL Buss G Tunggal L Pulverer G Immunostimulating activity of different dosages of mistletoe lectin-1 in patients with mammary carcinoma Arzneimittel-Forschung 1995 45 4 505 507 2-s2.0-0028934789 7779151
41 Maletzki C Linnebacher M Savai R Hobohm U Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy Cancer Immunology, Immunotherapy 2013 62 8 1283 1292 2-s2.0-84880917245 23832140
42 Hong C Lyu S The antimutagenic effect of mistletoe lectin ( Viscum album L. var. coloratum agglutinin) Phytotherapy Research 2012 26 5 787 790 2-s2.0-84859923010 22084060
43 Bogoeva V Ivanov I Kulina H Russev G Atanasova L A novel cytokinin-binding property of mistletoe lectin I from viscum album Biotechnology and Biotechnological Equipment 2013 27 1 3583 3585 2-s2.0-84874550766
44 Stauder H Kreuser E-D Mistletoe extracts standardised in terms of mistletoe lectins (ML I) in oncology: current state of clinical research Onkologie 2002 25 4 374 380 2-s2.0-0036380345 12232491
45 Schaller G Urech K Cytotoxicity of different viscotoxins and extracts from the European subspecies of Viscum album L Phytotherapy Research 1996 10 473 477
46 Tabiasco J Pont F Fournié J Vercellone A Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity European Journal of Biochemistry 2002 269 10 2591 2600 2-s2.0-0036111768 12027898
47 Kuttan G Kuttan R Reduction of leukopenia in mice by “Viscum album” administration during radiation and chemotherapy Tumori 1993 79 1 74 76 2-s2.0-0027284906 8497925
48 Becker H European Mistletoe: Taxonomy, Host Trees, Parts Used, Physiology 2000 Harwood Academic Publishers
49 Lev E Ephraim M Ben-Arye E European and Oriental mistletoe: From mythology to contemporary integrative cancer care European Journal of Integrative Medicine 2011 3 3 e133 e137 2-s2.0-80054870099
50 Yang Y Chen M Sha C Triterpenoids and triterpenoid saponins of Viscum liquidambaricolum Zhongguo Zhong Yao Za Zhi 2011 36 2 162 165 2-s2.0-79955955303 21506415
51 Zhao YL Wang XY Sun LX Fan RH Bi KS Yu ZG Cytotoxic constituents of Viscum coloratum Zeitschrift fur Naturforschung C 2012 67 3-4 129 134 2-s2.0-84860477219
52 Pieme CA Ngogang J Costache M In vitro antiproliferative and anti-oxidant activities of methanol extracts of Urena lobata and Viscum album against breast cancer cell lines Toxicological and Environmental Chemistry 2012 94 5 987 999 2-s2.0-84861522447
53 Hojjat SA Nasrollah G Ali F Cytotoxic effects of Iranian mistletoe extract on a panel of cancer cells Iranian Journal of Pharmaceutical Sciences 2006 2 3 157 162
54 Dashora N Sodde V Prabhu KS Lobo R In vitro cytotoxic activity of Dendrophthoe falcata on human breast adenocarcinoma Cells-MCF-7 International Journal of Cancer Research 2011 7 1 47 54 2-s2.0-79959323190
55 Johansson S Gullbo J Lindholm P Small, novel proteins from the mistletoe Phoradendron tomentosum exhibit highly selective cytotoxicity to human breast cancer cells Cellular and Molecular Life Sciences 2003 60 1 165 175 2-s2.0-0037275083 12613665
56 Jacobo-Salcedo MR Alonso-Castro A Salazar-Olivo L Antimicrobial and cytotoxic effects of Mexican medicinal plants Natural Product Communications 2011 6 12 1925 1928 22312741
57 Kelter G Schierholz JM Fischer IU Fiebig H Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro Anticancer Research 2007 27 1 223 234 2-s2.0-33847648144 17352237
58 Maier G Fiebig H Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro Anti-Cancer Drugs 2002 13 4 373 379 2-s2.0-0036242236 11984083
59 Knöpfl-Sidler F Viviani A Rist L Hensel A Human cancer cells exhibit in vitro individual receptiveness towards different Mistletoe extracts Pharmazie 2005 60 6 448 454 2-s2.0-22044434862 15997835
60 Beuth J Ko HL Schneider H Intratumoral application of standardized mistletoe extracts down regulates tumor weight via decreased cell proliferation, increased apoptosis and necrosis in a murine model Anticancer Research 2006 26 6B 4451 4456 2-s2.0-33845955943 17201168
61 Hugo F Schwitalla S Niggemann B Zänker KS Dittmar T Viscum album extracts Iscador P and Iscador M counteract the growth factor induced effects in human follicular B-NHL cells and breast cancer cells Medicina 2007 67 2 90 96 2-s2.0-34548483703
62 Eggenschwiler J von Balthazar L Stritt B Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir ( Abies pectinata ) BMC Complementary and Alternative Medicine 2007 7, article 14 2-s2.0-34249903618
63 Burger AM Mengs U Schüler JB Fiebig H Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro Arzneimittel-Forschung 2001 51 9 748 757 2-s2.0-0034837768 11642008
64 Burger AM Mengs U Kelter G Schüler JB Fiebig H No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extract in vitro Anticancer Research 2003 23 5 3801 3806 2-s2.0-0345305283 14666680
65 Ramaekers FCS Harmsma M Tusenius KJ Schutte B Werner M Ramos M Mistletoe extracts ( Viscum album L.) Iscador interact with the cell cycle machinery and target survival mechanisms in cancer cells Medicina 2007 67 2 79 84 2-s2.0-34548489890
66 Berger M Schmahl D Studies on the tumor-inhibiting efficacy of iscador in experimental animal tumors Journal of Cancer Research and Clinical Oncology 1983 105 3 262 265 2-s2.0-0020522181 6853588
67 Drees M Berger DP Dengler WA Direct cytotoxic effects of preparations used as unconventional methods in cancer therapy in human tumor xenografts in the clonogenic assay and in nude mice Immunodeficient Animals: Models for Cancer Research 1996 51 Basel, Switzerland Karger 115 122
68 Bock PR Friedel WE Hanisch J Karasmann M Schneider B Efficacy and safety of long-term complementary treatment with standardized european mistletoe extract ( Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma / results of a multicenter, comparative, epidemiological cohort study in Germany and Switzerland Arzneimittel-Forschung/Drug Research 2004 54 8 456 466 2-s2.0-4344630940 15460213
69 Piao BK Wang YX Xie GR Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial Anticancer Research 2004 24 1 303 309 2-s2.0-1442350530 15015612
70 Semiglazov V Stepula V Dudov A Schnitker J Mengs U Quality of life is improved in breast cancer patients by standardised mistletoe extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled Anticancer Research 2006 26 1519 1529 16619567
71 Beuth J Schneider B Schierholz JM Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative Epidemiological Cohort Study Anticancer Research 2008 28 1B 523 527 2-s2.0-40549134157 18383896
72 Büssing A Bücknerb U Enser-Weisb U Modulation of chemotherapy-associated immunosuppression by intravenous application of Viscum album L. extract (Iscador): a randomised phase II study European Journal of Integrative Medicine 2008 1 1 2 3
73 Tröger W Jezdić S Ždrale Z Tišma N Hamre HJ Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone Breast Cancer 2009 3 35 45 21556248
74 Eisenbraun J Scheer R Kröz M Schad F Huber R Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract Phytomedicine 2011 18 2-3 151 157 2-s2.0-78651322711 20724129
75 Tröger W Zdrale Z Stanković N Matijašević M Five-year follow-up of patients with early stage breast cancer after a randomized study comparing additional treatment with viscum album (L.) extract to chemotherapy alone Breast Cancer 2012 6 173 180 23150723
76 Anna-Maria LL Velasco MG Reinhard B Mistletoe treatments for minimising side effects of anticancer chemotherapy GMS Health Technology Assessment 2006 2 1 8
77 Kienle GS Kiene H Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts European Journal of Medical Research 2007 12 3 103 119 2-s2.0-34147101252 17507307
78 Horneber MA Bueschel G Huber R Linde K Rostock M Mistletoe therapy in oncology Cochrane Database of Systematic Reviews 2008 2 2-s2.0-44949265448
79 Ziegler R Grossarth-Maticek R Individual patient data meta-analysis of survival and psychosomatic self-regulation from published prospective controlled cohort studies for long-term therapy of breast cancer patients with a mistletoe preparation (iscador) Evidence-Based Complementary and Alternative Medicine 2010 7 2 157 166 2-s2.0-77952190319 18955332
80 Melzer J Iten F Hostanska K Saller R Efficacy and safety of mistletoe preparations (viscum album) for patients with cancer diseases Forschende Komplementarmedizin 2009 16 4 217 226 2-s2.0-70149121373 19729932
81 Kienle GS Kiene H Influence of Viscum album L ( European mistletoe ) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies Integrative Cancer Therapies 2010 9 2 142 157 2-s2.0-77954199043 20483874
82 Kienle GS Berrino F Büssing A Portalupi E Rosenzweig S Kiene H Mistletoe in cancer-a systematic review on controlled clinical trials European Journal of Medical Research 2003 8 3 109 119 2-s2.0-0242309722 12730032
83 Ostermann T Raak C Büssing A Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review BMC Cancer 2009 9, article 451 2-s2.0-74249108509
84 Kienle GS Glockmann A Schink M Kiene H Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research Journal of Experimental and Clinical Cancer Research 2009 28 1, article 79 2-s2.0-68349116044
85 Büssing A Raak C Ostermann T Quality of life and related dimensions in cancer patients treated with mistletoe extract ( Iscador ): a meta-analysis Evidence-Based Complementary and Alternative Medicine 2012 2012 8 pages 219402 2-s2.0-80052753545
86 Ostermann T Büssing A Retrolective studies on the survival of cancer patients treated with mistletoe extracts: a meta-analysis Explore 2012 8 5 277 281 2-s2.0-84865720142 22938746
87 Konrad U Renatus Z Documentation of published clinical trials and observational studies with Iscador 2006 Arlesheim, Switzerland Verein für Krebsforschung
88 Gutsch J Berger H Scholz G Denck H A prospective study of radically operated breast carcinoma with polychemotherapy, Helixor and untreated controls Deutsche Zeitschrift fur Onkologie 1988 20 4 94 101 2-s2.0-0023726646
89 Heiny B-M Additive therapie mit standardisiertem mistelextrakt reduziert die leukopenie und verbessert die lebensqualität von patientinnen mit fortgeschrittenem mammakarzinom unter palliativer chemotherapie (VEC-Schema) Krebsmedizin 1991 12 1 14
90 Borrelli E Evaluation of the quality of life in breast cancer patients undergoing lectin standardized mistletoe therapy Minerva Medica 2001 92 105 107
91 Grossarth-Maticek R Kiene H Baumgartner SM Ziegler R Use of iscador, an extract of European mistletoe (Viscum Album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study Alternative Therapies in Health and Medicine 2001 7 3 57 78 2-s2.0-0035004688 11347286
92 Kröz M Schad F Matthes B Pickartz H Girke M Blut- und gewebseosinophilie, mistellektin-antikörper und l ebensq ualität bei einer mammakarzinom-patientin unter intratumoraler und subkutaner misteltherapie Forsch Komplementärmed Kl. Naturheilkd 2002 9 160 167
93 Schumacher K Schneider B Reich G Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients Anticancer Research 2003 23 6 5081 5087 2-s2.0-0242277975 14981970
94 Semiglasov VF Stepula VV Dudov A Lehmacher W Mengs U The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial Anticancer Research 2004 24 2 1293 1302 2-s2.0-2442507986 15154663
95 Auerbach L Dostal V Václavik-Fleck I Scheer R Bauer R Becker H Fintelmann V Kemper F Schilcher H Signifikant höherer a nteil aktivierter NK-Zellen durch additive mistel therapie bei chemotherapierten mamma-ca-Patientinnen in einer prospektiv randomisierten doppelblinden studie Fortschritte in der Misteltherapie 2005 Essen, Germany KVC 543 554
96 Grossarth-Maticek R Ziegler R Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) Forschende Komplementarmedizin 2006 13 5 285 292 2-s2.0-33750388867 17057389
97 Loewe-Mesch A Kuehn JJ Borho K Adjuvant simultaneous treatment with mistletoe during chemotherapy for breast cancer—influence on immune parameters, quality of life and tolerability Forschende Komplementarmedizin 2008 15 1 22 30 2-s2.0-40549090910 18334811
98 Wode K Schneider T Lundberg I Kienle GS Mistletoe treatment in cancer-related fatigue: a case report Cases Journal 2009 2 1, article 77 2-s2.0-68349099164
99 Tröger W Connection between quality of life and neutropenia in breast cancer patients who were solely treated with chemotherapy or additionally with mistletoe therapy: results of a randomized study Deutsche Zeitschrift fur Onkologie 2011 43 2 58 67 2-s2.0-79960341277
100 Werner M Bock PR Hanisch J Stauder G Supportive therapy with mistletoe extract in tumor patients, results of four controlled pharmacoepidemiological cohort studies as basis for prospective studies (clinical report) Phytomedicine 2011 18 1 S12 S13
101 Brandenberger M Simões-Wüst AP Rostock M Rist L Saller R An exploratory study on the quality of life and individual coping of cancer patients during mistletoe therapy Integrative Cancer Therapies 2012 11 2 90 100 2-s2.0-84860238101 21733987
102 Tröger W Zdrale Z Tišma N Matijašević M Additional therapy with a mistletoe product during adjuvant chemotherapy of breast cancer patients improves quality of life: an open randomized clinical pilot trial Evidence-Based Complementary and Alternative Medicine 2014 2014 9 pages 430518
103 Yoon TJ Yoo YC Kang TB Lectins isolated from Korean mistletoe (Viscum album coloratum) induce apoptosis in tumor cells Cancer Letters 1999 136 1 33 40 2-s2.0-0033032518 10211936
104 Harmsma M Ummelen M Dignef W Tusenius KJ Ramaekers FCS Effects of mistletoe (Viscum album L.) extracts Iscador on cell cycle and survival of tumor cells Drug Research 2006 56 6 474 482 2-s2.0-33748636232 16927529
105 Büssing A Immune modulation using mistletoe ( Viscum album L.) extracts Iscador Arzneimittelforschung 2006 56 6 508 515 16927532
106 Hajto T Immunomodulatory effects of iscador: a Viscum album preparation Oncology 1986 43 1 51 65 2-s2.0-0022974278 2433654
107 Beuth J Ko HL Gabius H Burrichter H Oette K Pulverer G Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients Clinical Investigator 1992 70 8 658 661 2-s2.0-0026779122 1392440
108 Beuth J Ko HL Tunggal L Geisel J Pulverer G Comparative studies on the immunoactive potency of galactoside-specific lectin from mistletoe/pure substance against standardized extract Drug Research 1993 43 2 166 169 2-s2.0-0027465312 7681287
109 Beuth J Gabius H-J Steuer MK Geisel J Ko HL Pulverer G Influence of mistletoe lectin administration on defined acute phase reactants in cancer patients Medizinische Klinik 1993 88 5 287 290 2-s2.0-0027153254 7687001
110 Heiny B-M Beuth J Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces β -endorphin release and immunopotentiation in breast cancer patients Anticancer Research 1994 14 3B 1339 1342 2-s2.0-0028040372 8067703
111 Heiny BM Albrecht V Beuth J Correlation of immune cell activities and β -endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract Anticancer Research 1998 18 1 583 586 2-s2.0-0031922838 9568181
112 Pae HO Seo WG Oh GS Potentiation of tumor necrosis factor- α -induced apoptosis by mistletoe lectin Immunopharmacology and Immunotoxicology 2000 22 4 697 709 2-s2.0-0033679213 11105782
113 Kovacs E Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract Biomedicine and Pharmacotherapy 2000 54 6 305 310 2-s2.0-0033856293 10989963
114 Büssing A Bischof M Hatzmann W Prevention of surgery-induced suppression of granulocyte function by intravenous application of a fermented extract from Viscum album L. in breast cancer patients Anticancer Research C 2005 25 6 4753 4757 2-s2.0-28444445184
115 Büssing A Stumpf C Tröger W Schietzel M Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts Anticancer Research 2007 27 4 2903 2910 2-s2.0-34547769418 17695469
116 Büssing A Tröger W Stumpf C Schietzel M Local reactions to treatments with viscum album L. extracts and their association with T-lymphocyte subsets and quality of life Anticancer Research 2008 28 3 1893 1897 2-s2.0-45949086376 18630477
117 Heinzerling L von Baehr V Liebenthal C von Baehr R Volk H Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro , ex vivo , and in vivo Journal of Clinical Immunology 2006 26 4 347 359 2-s2.0-33745927709 16705487
118 Gardin NE Immunological response to mistletoe ( Viscum album L.) in cancer patients: a four-case series Phytotherapy Research 2009 23 3 407 411 2-s2.0-61449189674 19003944
119 Son GS Ryu WS Kim HY Woo SU Park KH Bae JW Immunologic response to mistletoe extract (Viscum album L.) after conventional treatment in patients with operable breast cancer Journal of Breast Cancer 2010 13 1 14 18 2-s2.0-77953196147
120 Hagens C Giese T Staudt A Does a treatment with Viscum album (Iscador [R] P) in patients with breast cancer influence the expression of the T-cell receptor (TCR)-zeta chains of T - and NK-cells?(Report) Phytomedicine 2011 18 p. S24
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.